Two American aid workers who were infected with Ebola have been discharged from an Atlanta hospital, where doctors say they pose no risk to public safety.
Dr. Kent Brantly of Texas was given ZMapp, an experimental drug treatment used on a handful of patients in the West African outbreak and produced by U.S.-based Mapp Biopharmaceutical.